Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8787532 | Journal of Thoracic Oncology | 2018 | 21 Pages |
Abstract
In this analysis, we have noted significant differences in radiosensitivity on the basis of primary histologic type of lung metastases and have modeled the biologically effective dose necessary to optimize local control. This study suggests that primary histologic type may be an additional factor to consider in selection of SBRT dose to the lung and that dose personalization may be feasible.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kamran A. MD, Jacob G. MD, John A. MD, Arash O. MD, G. Daniel MD, PhD, Bradford A. MD, Jimmy J. MD, PhD, Anders E. PhD, Eric A. PhD, Steven A. PhD, Thomas J. MD, Javier F. MD,